Clinical Trial Update: Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of Bevirimat monotherapy in HIV treatment-experienced patients for 2 weeks has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bevirimat (bevirimat)

Snippet

Sponsor: Myrexis Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED